Tau pathology on MAPT R406W mutation carriers is known to be similar to AD tau pathology46,47 and reactive to AD tau-PET tracers4,48–50, further supporting our finding that MTBR-tau243 is a specific biomarker to AD-like tau pathology. Here, MAPT is linked to Alzheimer disease.